
|Articles|May 25, 2022
Promontory Therapeutics Appoints Johan Baeck, MD, as Executive Vice President and Chief Medical Officer
Advertisement
Promontory Therapeutics Inc. announced the appointment of Johan Baeck, MD, as Executive Vice President and Chief Medical Officer. Dr. Baeck joins Promontory Therapeutics from Jounce Therapeutics where he served as Senior Vice President, Clinical Development and Medical Affairs.
Read more about the appointment
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Beyond Amyloid, Part One (of two): Tau and Microglia Redefine the Alzheimer’s Pipeline
2
What the Peptide Advisory Vote Actually Means: Q&A with James LaValle
3
M&A Roundup: IntraGel & UroGen Sign Collaboration & Investment Agreements, Lupin & Tenpoint Form Commercialization Collaboration
4
Hanmi Pharm Enters $2.3 Billion Licensing Agreement with Genentech for HM17321
5




